Severe Hypoglycaemia Leading to Hospital Admission in Type 2 Diabetic Patients Aged 80 Years or Older

被引:52
作者
Greco, D. [1 ]
Pisciotta, M. [1 ]
Gambina, F. [1 ]
Maggio, F. [1 ]
机构
[1] S Biagio Hosp, Div Diabetol, Marsala, TP, Italy
关键词
severe hypoglycaemia; type; 2; diabetes; elderly; risk factors; long-acting sulphonylurea; dementia; INSULIN THERAPY; MELLITUS; RISK; SULFONYLUREAS; GLIBENCLAMIDE; REPAGLINIDE; KNOWLEDGE; SYMPTOMS; DEMENTIA; ANALOGS;
D O I
10.1055/s-0029-1241823
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Evidence is mounting that hypoglycaemia among elderly diabetic patients is a very real and costly concern. Objective of this study was to determine the incidence and risk factors for developing severe hypoglycaemia leading to hospital admission, among type 2 diabetic subjects aged 80 years or older. Hypoglycaemia was defined as a symptomatic event requiring treatment with i.v. glucose and confirmed by a blood glucose determination <50mg/dl. During a eight-year period severe hypoglycaemia was identified in 99 subjects. These patients were found to have a reduced cognitive ability, a heavy burden of comorbid disease and a HbA1c values of 5.9%. Of the hypoglycaemic episodes, 76 occurred in patients taking glibenclamide. Diabetes therapy was prescribed by general practitioners in 85 of them. Only 26 patients performed regular home blood glucose self-monitoring. Severe hypoglycaemia is a serious and not uncommon metabolic emergency among patients with type 2 diabetes aged 80 years or older; it is more frequent in patients with considerable comorbidity undergoing aggressive diabetes management and in users of a long-acting sulphonylurea. In elderly subject, each patient's risk for hypoglycaemia should be considered and therapy should be individualized accordingly; in our opinion, a great number of episodes may be avoided by teaching the principles of blood glucose monitoring and involving general practitioners in outpatients management of diabetes mellitus.
引用
收藏
页码:215 / 219
页数:5
相关论文
共 32 条
  • [1] ALLICAR M, 2000, PRESSE MED, V29, P837
  • [2] Hypoglycaemia in Type 2 diabetes
    Amiel, S. A.
    Dixon, T.
    Mann, R.
    Jameson, K.
    [J]. DIABETIC MEDICINE, 2008, 25 (03) : 245 - 254
  • [3] ASPLUND K, 1983, DIABETOLOGIA, V24, P412
  • [4] The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes
    Baxter, Mike A.
    [J]. ACTA DIABETOLOGICA, 2008, 45 (04) : 253 - 268
  • [5] Drug-induced hypoglycemic coma in 102 diabetic patients
    Ben-Ami, H
    Nagachandran, P
    Mendelson, A
    Edoute, Y
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (03) : 281 - 284
  • [6] Risk of dementia in diabetes mellitus: a systematic review
    Biessels, GJ
    Staekenborg, S
    Brunner, E
    Brayne, C
    Scheltens, P
    [J]. LANCET NEUROLOGY, 2006, 5 (01) : 64 - 74
  • [7] Chau Diane, 2001, Clinical Diabetes, V19, P172, DOI 10.2337/diaclin.19.4.172
  • [8] Hypoglycaemia in elderly patients with diabetes mellitus - Causes and strategies for prevention
    Chelliah, A
    Burge, MR
    [J]. DRUGS & AGING, 2004, 21 (08) : 511 - 530
  • [9] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE
    COCKCROFT, DW
    GAULT, MH
    [J]. NEPHRON, 1976, 16 (01) : 31 - 41
  • [10] Repaglinide - A review of its therapeutic use in type 2 diabetes mellitus
    Culy, CR
    Jarvis, B
    [J]. DRUGS, 2001, 61 (11) : 1625 - 1660